Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-11-040037
Filing Date
2011-07-19
Accepted
2011-07-19 16:56:39
Documents
1
Period of Report
2011-06-02

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c20131_4ax0.html 4/A  
1 MAIN DOCUMENT DESCRIPTION c20131_4ax0.xml 4/A 4162
  Complete submission text file 0001209191-11-040037.txt   5614
Mailing Address 7 WELLS AVENUE STE 34 NEWTON MA 02459
Business Address 7 WELLS AVENUE STE 34 NEWTON MA 02459 617-559-0033
GALECTIN THERAPEUTICS INC (Issuer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5118 HOLLY TERRACE HOUSTON TX 77056
Business Address
PRESSLER HERMAN PAUL (Reporting) CIK: 0001522481 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-31791 | Film No.: 11975683